1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2015

Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2015" provides an overview of Obstructive Pulmonary Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Pulmonary Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Obstructive Pulmonary Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Obstructive Pulmonary Disease to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Obstructive Pulmonary Disease to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Obstructive Pulmonary Disease 25
Subjects Recruited Over a Period of Time 37
Clinical Trials by Sponsor Type 38
Prominent Sponsors 39
Top Companies Participating in Obstructive Pulmonary Disease Therapeutics Clinical Trials 40
Prominent Drugs 41
Latest Clinical Trials News on Obstructive Pulmonary Disease 42
May 27, 2015: Phase I clinical trial of inhaled molgramostim has commenced 42
Clinical Trial Profiles 43
Clinical Trial Overview of Top Companies 43
GlaxoSmithKline Plc 43
Clinical Trial Overview of GlaxoSmithKline Plc 43
C. H. Boehringer Sohn AG and Co. KG 57
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 57
AstraZeneca Plc 68
Clinical Trial Overview of AstraZeneca Plc 68
Novartis AG 77
Clinical Trial Overview of Novartis AG 77
Pfizer Inc. 85
Clinical Trial Overview of Pfizer Inc. 85
Chiesi Farmaceutici SpA 88
Clinical Trial Overview of Chiesi Farmaceutici SpA 88
Quintiles Transnational Holdings Inc. 91
Clinical Trial Overview of Quintiles Transnational Holdings Inc. 91
Almirall, S.A. 93
Clinical Trial Overview of Almirall, S.A. 93
Takeda Pharmaceutical Company Limited 96
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 96
Forest Laboratories, Inc. (Inactive) 99
Clinical Trial Overview of Forest Laboratories, Inc. (Inactive) 99
Clinical Trial Overview of Top Institutes / Government 102
Imperial College London 102
Clinical Trial Overview of Imperial College London 102
Laval University 103
Clinical Trial Overview of Laval University 103
University of Milan 104
Clinical Trial Overview of University of Milan 104
University of Dundee 105
Clinical Trial Overview of University of Dundee 105
Dartmouth-Hitchcock Medical Center 106
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 106
Klinikum Berchtesgadener Land der Schon-Kliniken 107
Clinical Trial Overview of Klinikum Berchtesgadener Land der Schon-Kliniken 107
University Medical Center Freiburg 108
Clinical Trial Overview of University Medical Center Freiburg 108
Katholieke Universiteit Leuven 109
Clinical Trial Overview of Katholieke Universiteit Leuven 109
University Hospital Basel 110
Clinical Trial Overview of University Hospital Basel 110
Assistance Publique - Hopitaux de Paris 111
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 111
Five Key Clinical Profiles 112
Appendix 189
Abbreviations 189
Definitions 189
Research Methodology 190
Secondary Research 190
About GlobalData 191
Contact Us 191
Disclaimer 191
Source 191

List of Tables
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Obstructive Pulmonary Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Obstructive Pulmonary Disease to Respiratory Clinical Trials, G7 Countries (%), 2015* 15
Obstructive Pulmonary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Obstructive Pulmonary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Obstructive Pulmonary Disease to Respiratory Clinical Trials, E7 Countries (%), 2015* 18
Obstructive Pulmonary Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Obstructive Pulmonary Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Obstructive Pulmonary Disease Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Obstructive Pulmonary Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Obstructive Pulmonary Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 29
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 37
Obstructive Pulmonary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 38
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 39
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 40
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 41
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 43
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 57
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 68
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 77
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 85
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2015* 88
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Quintiles Transnational Holdings Inc., 2015* 91
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2015* 93
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 96
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc. (Inactive), 2015* 99
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2015* 102
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Laval University, 2015* 103
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2015* 104
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2015* 105
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2015* 106
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Klinikum Berchtesgadener Land der Schon-Kliniken, 2015* 107
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Freiburg, 2015* 108
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2015* 109
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2015* 110
Obstructive Pulmonary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 111

List of Figures
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Obstructive Pulmonary Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Obstructive Pulmonary Disease to Respiratory Clinical Trials, G7 Countries (%), 2015* 15
Obstructive Pulmonary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Obstructive Pulmonary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Obstructive Pulmonary Disease to Respiratory Clinical Trials, E7 Countries (%), 2015* 18
Obstructive Pulmonary Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Obstructive Pulmonary Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Obstructive Pulmonary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 37
Obstructive Pulmonary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 38
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 39
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 40
Obstructive Pulmonary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 41
GlobalData Methodology 190

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

  • $ 4995
  • Industry report
  • September 2016
  • by GBI Research

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Summary Gastric cancer is characterized by the formation of malignant ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.